Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

US Patent 11872200 · Granted Jan 16, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Enhancing GABA's ability to modulate immune responses2024
Enhancing GABA's ability to modulate immune responses2024
GABA agonists in the treatment of disorders associated with metabolic syndrome a2021
GABA agonists in the treatment of disorders associated with metabolic syndrome a2021
GABA agonists in the treatment of disorders associated with metabolic syndrome a2019
GABA agonists in the treatment of disorders associated with metabolic syndrome a2019
GABA agonists in the treatment of disorders associated with metabolic syndrome a2017
GABA agonists in the treatment of disorders associated with metabolic syndrome a2017
GABA agonists in the treatment of disorders associated with metabolic syndrome a2015
GABA agonists in the treatment of disorders associated with metabolic syndrome a2015
Cloned glutamic acid decarboxylase2015
DNA molecules encoding opioid receptors and methods of use thereof2010